Skip to content

Role of Angiotensin II in Insulin-induced Microvascular Activity

Role of Angiotensin II in Insulin-induced Microvascular Activity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01024543
Enrollment
18
Registered
2009-12-02
Start date
2006-10-31
Completion date
2009-11-30
Last updated
2009-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Sensitivity, Microcirculation

Keywords

Angiotensin II

Brief summary

In this study we hypothesize infusion of Angiotensin II improves the insulin-induced microvascular dilatation and therefore insulin-mediated glucose uptake. Objectives: Does infusion of Angiotensin II increase insulin-mediated glucose uptake via enhanced insulin-mediated microvascular function in healthy subjects?

Interventions

DRUGAngiotensin II

Angiotensin II

DRUGPhenylephrine

Phenylephrine

DRUGPlacebo

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1.18-60 years 2.Caucasian 3.Blood pressure \<140/90 mmHg.

Exclusion criteria

1. Obesity (BMI\>27kg/m2) 2. Cardiovascular disease (stroke, coronary artery disease, peripheral vascular disease, heart failure) 3. Impaired glucose tolerance or diabetes mellitus according to the criteria of the ADA 4. Smoking 5. Alcohol use \>4U/day 6. Use of medication (antihypertensive drugs, lipid lowering drugs, corticosteroids, NNSAIDs) 7. Pregnancy 8. Wearing contact lenses

Design outcomes

Primary

MeasureTime frame
functional recruitment of capillaries in the skinJanuary 2009

Secondary

MeasureTime frame
perfused capillary density in the nailfoldJanuary 2009
Endothelium- (in)dependent vasodilatation of finger skin microcirculationJanuary 2006
Insulin sensitivityJanuary 2009

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026